Damian Aguirrechu

Healthcare & AI | GTM Operator for Growth-Stage Healthcare & Medtech | Fractional Marketing Leader

National Foundation for Integrative Medicineex-Optumex-Med Claims Compliance Corporation

“

I help PE-backed provider platforms turn VBC, AI, and reimbursement complexity into a repeatable growth engine—without adding sales noise or buying Companies usually call me right after something has changed.

More

An acquisition closed. A new division got stood up inside a bigger company. The product pivoted, or new leadership walked in. Whatever the trigger, the go-to-market that got them there no longer fits what they've become, and revenue is where that shows up first. The pattern is familiar by now. Pipeline looks healthy, but enterprise deals stall. Product, positioning, and sales are each doing their job, just not the same job. My work is finding where those pieces stopped agreeing with each other and fixing it inside live deals, not in a slide deck that gets filed away. I've spent 15+ years in healthcare and healthtech commercial roles doing versions of this: running a $250M+ P&L, taking one business into 20+ countries ($47M), growing a product line to $29M, building sales and marketing teams past 100 people. Most of that happened in regulated markets, where buying committees are big and adoption is slow. That's the environment most healthcare AI companies are now trying to sell into, and it punishes vague positioning fast. Right now I'm taking fractional marketing engagements and advisory work with growth-stage healthcare and healthtech companies. If deals are stalling and nobody can quite say why, that's usually where I start.